Willow Biosciences Projecting Over $1M in 2Q Revenue | TSX:WLLW, OTCQB:CANSF

Proactive InvestorsJun 27 04:31 ET

Willow Biosciences Brief: Announced Multi-product Development and Licensing Partnership With Laurus Labs for Manufacturing Active Pharmaceutical Ingredients

MT NewswiresJun 26 16:33 ET

Willow Biosciences Brief: Announces Its First Patent Being Issued; Anticipates Filing Another Five Patents in 2024 Primarily Related to Its Steroid Production Platform

MT NewswiresJun 26 16:32 ET

Willow Bioscience Announces 3 Million Dollar Fundraising to Support Partnership With Laurus Labs | TSX:WLLW, OTCQB:CANSF

Proactive InvestorsJun 7 08:19 ET

Willow Biosciences to Launch a $3m Brokered Placement | TSX:WLLW, OTCQB:CANSF

Proactive InvestorsJun 3 03:59 ET

Press Release: WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Dow JonesMay 13 07:00 ET